Reports for FRESENIUS KABI CANADA LTD
Company Name
FRESENIUS KABI CANADA LTD
Totals |
||
Shortage reports |
366 |
|
| Actual shortage: | 9 (2%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 5 (1%) | |
| Resolved: | 352 (96%) | |
Discontinuation Reports |
2 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 2 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
51 (14%) |
|
Overdue reports |
3 (33%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MILRINONE LACTATE INJECTION, USP | 1MG | SOLUTION | Resolved | 2022-08-04 | 2022-08-25 | 166152 |
| MILRINONE LACTATE INJECTION, USP | 1MG | SOLUTION | Resolved | 2022-08-24 | 2022-11-02 | 167705 |
| MILRINONE LACTATE INJECTION, USP | 1MG | SOLUTION | Resolved | 2022-11-07 | 2023-04-03 | 173929 |
| MILRINONE LACTATE INJECTION, USP | 1MG | SOLUTION | Resolved | 2022-11-07 | 2023-04-03 | 173932 |
| MILRINONE LACTATE INJECTION, USP | 1MG | SOLUTION | Resolved | 2023-11-01 | 2024-04-23 | 208900 |
| MITOXANTRONE INJECTION | 2MG | SOLUTION | Resolved | 2020-04-20 | 2020-05-06 | 112481 |
| MORPHINE SULFATE INJECTION, USP | 2MG | SOLUTION | Resolved | 2021-09-24 | 2021-10-06 | 146195 |
| MORPHINE SULFATE INJECTION, USP | 2MG | SOLUTION | Resolved | 2024-11-20 | 2025-01-08 | 243494 |
| MORPHINE SULFATE INJECTION, USP | 10MG | SOLUTION | Resolved | 2021-10-27 | 2021-12-17 | 148318 |
| MORPHINE SULFATE INJECTION, USP | 10MG | SOLUTION | Resolved | 2025-04-03 | 2025-07-23 | 253988 |
| MOXIFLOXACIN INJECTION | 400MG | SOLUTION | Resolved | 2020-05-21 | 2020-06-13 | 115558 |
| MOXIFLOXACIN INJECTION | 400MG | SOLUTION | Resolved | 2021-10-06 | 2022-01-06 | 146725 |
| MOXIFLOXACIN INJECTION | 400MG | SOLUTION | Resolved | 2022-01-07 | 2022-12-04 | 152362 |
| MOXIFLOXACIN INJECTION | 400MG | SOLUTION | Resolved | 2024-04-04 | 2024-09-12 | 224325 |
| MOXIFLOXACIN INJECTION | 400MG | SOLUTION | Actual shortage | 2025-05-29 | 2025-11-18 | 258830 |
| OXYTOCIN INJECTION, USP | 10UNIT | SOLUTION | Resolved | 2019-09-13 | 2019-11-28 | 93921 |
| OXYTOCIN INJECTION, USP | 10UNIT | SOLUTION | Resolved | 2019-10-04 | 2019-11-28 | 95462 |
| OXYTOCIN INJECTION, USP | 10UNIT | SOLUTION | Resolved | 2021-10-20 | 2022-01-06 | 147619 |
| OXYTOCIN INJECTION, USP | 10UNIT | SOLUTION | Resolved | 2022-05-15 | 2023-04-05 | 160656 |
| OXYTOCIN INJECTION, USP | 10UNIT | SOLUTION | Resolved | 2022-08-19 | 2022-11-02 | 167490 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PIPERACILLIN AND TAZOBACTAM FOR INJECTION | 4.5G 36G | POWDER FOR SOLUTION | Discontinued | 2024-08-13 | 2024-08-20 | 235203 |
| SODIUM BICARBONATE INJECTION, USP | 42MG | SOLUTION | Discontinued | 2024-10-03 | 2024-10-03 | 239180 |
Showing 1 to 2 of 2